Le Lézard
Classified in: Health

DMEhub Partners with Kno2 to Further Enhance the Speed and Simplicity of its e-Prescribing Platform for Durable Medical Equipment


BOISE, Idaho and LAKE FOREST, Calif., Jan. 20, 2021 /PRNewswire-PRWeb/ -- DMEhub®, a leading e-prescribe platform for ordering medical equipment and supplies, is now Connected by Kno2® to significantly enhance and further automate the durable medical equipment ordering process.

"The partnership with Kno2 gives DMEhub a greater ability to meet prescribers where they are at technologically and to seamlessly integrate into their workflows," said Ken Hodel, Vice President of Business Development for DMEhub. "Now, DMEhub can use a variety of standards to integrate with providers' systems, reducing manual effort and rework and replacing them with data and automation. Kno2's experience, approach and technology made them the logical choice to expand our interoperability capabilities."

Unlike orders for medications or lab tests where only a valid, signed prescription is required, most DME orders require that additional documentation be included to support medical necessity. Often the additional documentation is incomplete or missing, which results in back-and-forth rework between the prescriber and DME supplier. In addition, the reliance on fax machines and phone calls to obtain the required documentation may further slow down response times ? ultimately causing delays in setting patients up on life-changing therapies.

DMEhub replaces the burdensome inefficiency of a paper-driven process with an intelligent, easy-to-use online platform that allows more than 95% of medical equipment orders to be accepted on the first submission. By removing the rework associated with medical equipment orders, patients get what they need when they need it.

With Kno2's Interoperability as a Servicetm (IAAS), DMEhub integrates with virtually every electronic health record (EHR) system to save time, support the evidence for medical necessity and avoid duplicate orders. DMEhub reduces rework by automating the collection and generation of the exact documentation needed to submit complete and accurate orders and sends it to the DME supplier in one digital package. This is accomplished with the utilization of standards-based exchange methods like Direct secure messaging via the DirectTrusttm framework, query-based record exchange via Carequality and Fast Healthcare Interoperability Resources (FHIR).

"We are delighted that DMEhub chose to partner with Kno2 as their interoperability service provider" said Therasa Bell, president and CTO at Kno2. "Because DMEhub had the insight to integrate broad-based interoperability into their platform, becoming Kno2 Connected moved their workflow from fax, past expensive point-to-point interfaces, to an offering that can fit in every care setting that has a certified EHR."

About DMEHub

DMEhubtm is a web-based ordering platform that is available to all durable medical equipment prescribers and suppliers. As one of the leading e-prescribe platforms, DMEhubtm uses intelligent logic to identify the right product and qualify the medical necessity of every order, resulting in a significant reduction in the rework and delays often associated with the ordering of durable medical equipment. DMEhubtm also offers a single source for inputting and tracking orders that can be seamlessly integrated with electronic health record (EHR) systems and is always free to healthcare providers. For more information about DMEhub, visit http://www.dmehub.com.

About Kno2
Kno2® is leading healthcare's path to interoperability across every patient care setting with the capability to send, receive, find and use patient information with everyone. Through Kno2's Interoperability as a Servicetm, common exchange methods including cloud fax, Direct secure messaging using the DirectTrusttm framework, patient information query with providers live on Carequality, including those connected through CommonWell Health Alliance®, IHE profiles, HL7 messaging, Fast Interoperability Healthcare Resources (FHIR), patient care networks (Referrals, ACOs, HIEs), and other forms of exchange are standardized into simple send and receive workflows, from virtually any source. The innovative technology has the intelligence to determine the most interoperable form of exchange to ensure that content flows freely between systems and providers. All this functionality is available to providers and technology vendors through a simple set of REST-based APIs or through a Kno2 portal. For more information about Kno2, visit http://www.kno2.com.

Media Contact

Tina Marie Feldmann, Kno2, +1 4802915491, [email protected]

Ken Hodel, DMEHub, [email protected]

 

SOURCE Kno2


These press releases may also interest you

at 16:28
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...

at 16:20
The Board of Directors of Revvity , today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024. About Revvity ...

at 16:20
Edwards Lifesciences today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6 billion Q1 TAVR sales grew 6%; constant currency sales...

at 16:16
A functional assessment of Bacillus subtilis PLSSC (SEBtilistm) demonstrated its antimicrobial activity and capability to offer health benefits through industrial processing and the digestion process, showing its value-add in functional foods,...

at 16:15
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...



News published on and distributed by: